TCG Crossover Management, LLC

Q4 2024 13F Holdings

  • Location
    palo alto, CA
  • Num holdings

    38

  • Value ($000)

    $1,023,349

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001839948
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
CGON
CGON

CG ONCOLOGY INC

COMM
156944100
$105.26M
10 %

3,670,206

DYN
DYN

DYNE THERAPEUTICS INC

COMM
26818M108
$62.44M
6 %

2,650,150

XNCR
XNCR

XENCOR INC

COMM
98401F105
$56.35M
6 %

2,452,138

COGT
COGT

COGENT BIOSCIENCES INC

COMM
19240Q201
$54.32M
5 %

6,964,375

CNTA
CNTA

CENTESSA PHARMACEUTICALS PLC

ADRS
152309100
$48.42M
5 %

2,890,816

OCUL
OCUL

OCULAR THERAPEUTIX INC

COMM
67576A100
$45.43M
4 %

5,319,148

---

UPSTREAM BIO INC

COMM
91678A107
$44.86M
4 %

2,801,763

---

ABIVAX SA AMERICAN DEPOSITARY SHARES

ADRS
00370M103
$44.33M
4 %

6,056,596

YB4P
YB4P

SAVARA INC

COMM
805111101
$37.95M
4 %

12,362,205

TNGX
TNGX

TANGO THERAPEUTICS INC

COMM
87583X109
$33.17M
3 %

10,736,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 38